Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Ingoa hua:

    Vorinostat CAS 149647-78-9

  • Kōeke:

    Pharmaceutical grade/Cosmetic grade

  • Āhuatanga:

    paura ma

  • Tapeke:

    25kg/pahū

  • MOQ:

    1 kilo

  • Rokiroki:Wahi maroke Matao
  • ora papa:2 tau


Nga korero

Tohu

Whakaahuatanga Hua

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Taupānga
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Nga painga

He maha nga wheketere kounga teitei me te mahi tahi, ka taea e koe te whakarato i nga hua o te kounga teitei me nga utu whakataetae. Ka taea hoki e matou te tuku utu mo nga hokonga nui.A ka mahi tahi matou me te maha o nga kamupene kawe utanga ngaio, ka taea te tuku hua ma te humarie me te pai ki o ringaringa. Ko te wa tuku mo nga ra 3-20 i muri i te whakapumautanga o te utu.

 

Whakatakotoranga

 

Te tuku me te utu


 

FAQ

1. He wheketere koe, he kamupene hokohoko ranei?
He kamupene matou e whakauru ana i te ahumahi me te hokohoko, e whakarato ana i te ratonga kotahi-mutu. Ka taea e OEM te whakaae.

2. Kei te whakarato koe i nga tauira? He kore utu, he taapiri ranei?
Ko nga tauira kore utu.Ko te utu utauta a te tauira me utu e to taha.

3. Kei a koe etahi tiwhikete e pa ana ki te mana kounga?
ISO 9001: Tiwhikete 2008 hei whakarite i te kounga.

4. He aha te mea me whakarato e au ki te tiki korero?
Pls whakamohio mai ki a matou mo te momo hua e hiahiatia ana e koe, te rahinga ota, te wahitau me nga whakaritenga motuhake.Ka mahia te korero mo to tohutoro i te waa.

5. He aha te ahua o te tikanga utu e pai ana koe? He aha nga momo tikanga e whakaaetia ana?
Nga Tikanga Tukunga Whakaaetia: FOB,CFR,CIF,EXW;
Moni Utu Whakaaetia:USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Te Reo Korero:Maori.

 

Mena kei te pirangi koe ki a maatau hua, ka taea e koe te kowhiri ki te waiho i o korero ki konei, a ka tata tonu te korero ki a koe.


Tuhia to korero ki konei ka tukuna mai ki a matou